Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $24.33 +0.34 (+1.42%) (As of 12/20/2024 04:32 PM ET) Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsRatings Top 50 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1SRRKScholar Rock$44.78+6.4%3.47%10,0342WVEWave Life Sciences$13.51+2.4%2.03%14,6053Bny Mellon Cash Reserve UsdN/A1.98%217,2094SMMTSummit Therapeutics$17.87-2.9%1.97%11,6975RXRXRecursion Pharmaceuticals$6.03-1.0%1.75%25,3876PRAXPraxis Precision Medicines$76.52+5.1%1.67%2,362 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 7EWTXEdgewise Therapeutics$30.78-0.1%1.52%5,2868ACLXArcellx$75.54+0.4%1.48%1,6959CNTACentessa Pharmaceuticals$17.16-2.2%1.47%9,53610IRONDisc Medicine$64.50+2.5%1.41%2,41811VRDNViridian Therapeutics$19.03+1.6%1.38%7,19812ZYMEZymeworks$14.14+4.1%1.37%10,38813ERASErasca$2.54+3.7%1.28%43,40614REPLReplimune Group$12.49+4.0%1.23%10,00215KYMRKymera Therapeutics$40.66+3.9%1.18%2,70716IGMSIGM Biosciences$6.90-2.1%1.17%11,91417QUREuniQure$16.98+9.8%1.17%18,02818BHVNBiohaven$36.26+2.6%1.16%2,83619ARQTArcutis Biotherapeutics$14.99+6.2%1.15%10,13120ORICORIC Pharmaceuticals$8.21+6.8%1.14%12,31621VERAVera Therapeutics$42.60+1.3%1.14%2,53122RVMDRevolution Medicines$44.06+1.8%1.13%2,38623AKROAkero Therapeutics$29.34+3.3%1.12%3,84024MLTXMoonLake Immunotherapeutics$52.17+0.6%1.12%2,21725PLRXPliant Therapeutics$13.21-0.7%1.12%7,90526NRIXNurix Therapeutics$19.83-1.0%1.11%5,65627BLTEBelite Bio$64.12+1.1%1.10%1,89628VERVVerve Therapeutics$5.74+11.2%1.10%16,89529PTGXProtagonist Therapeutics$41.49+4.9%1.09%2,75630XNCRXencor$24.13+0.5%1.08%4,43531PCVXVaxcyte$86.53+0.4%1.07%1,27732CRNXCrinetics Pharmaceuticals$53.60+1.6%1.05%2,01633NUVLNuvalent$84.22-0.5%1.03%1,19734DNLIDenali Therapeutics$21.45-0.2%1.00%4,27435KROSKeros Therapeutics$17.03+0.7%0.99%1,91236BEAMBeam Therapeutics$29.01+8.0%0.97%3,75237ELVNEnliven Therapeutics$22.47-1.7%0.96%4,29838SLNOSoleno Therapeutics$45.180.0%0.96%2,10539XENEXenon Pharmaceuticals$38.63-0.7%0.96%2,49040ABUSArbutus Biopharma$3.210.94%29,942Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW41IMVTImmunovant$25.86+0.8%0.93%3,55142APGEApogee Therapeutics$47.71+1.5%0.92%2,19343MLYSMineralys Therapeutics$12.34+4.3%0.92%7,46344COGTCogent Biosciences$7.84+0.5%0.91%10,54045PHVSPharvaris$19.57+2.9%0.91%5,22246CRGXCARGO Therapeutics$14.90+10.3%0.90%5,51147RNAAvidity Biosciences$31.82+2.5%0.89%2,37048ETNB89bio$7.94+12.9%0.88%10,18749SLRNAcelyrin$3.15-2.2%0.88%21,69950CGONCG Oncology$28.67+2.3%0.88%2,715 Geographic ExposureUnited States86.3%Netherlands2.5%Canada2.4%Cayman Islands0.8%Singapore0.8%Virgin Islands, British0.8%Ireland0.7%Currency ExposureUSD100.0%Sector ExposureHealth Care24.3%Consumer Discretionary0.8%Energy0.8%Industry ExposureBiotechnology22.7%Diversified Consumer Services1.6%Pharmaceuticals0.8%Renewable Energy0.8%SubIndustry ExposureBiotechnology18.7%Pharmaceuticals2.4%Renewable Energy Equipment0.8%Coupon Exposure0-22.2% Related Companies and Tools Related Companies JDOC Portfolio PILL Portfolio FTXH Portfolio MEDX Portfolio MEDI Portfolio BIS Portfolio HYLG Portfolio LGHT Portfolio RXD Portfolio GDOC Portfolio This page (NYSEARCA:BBC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
